Get started
Author

Olivier Vitse

Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
2022 · Mazen M. Dimachkie, Richard J. Barohn, et al. · Neurology · 48
PDF
New imidazo[1,2-a]pyrazine derivatives with bronchodilatory and cyclic nucleotide phosphodiesterase inhibitory activities
1999 · Olivier Vitse, Florence Laurent, et al. · Bioorganic & Medicinal Chemistry · 29
Endothelial‐protective effects of a G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist, SAR247799, in type‐2 diabetes rats and a randomized placebo‐controlled patient trial
2020 · Luc Bergougnan, Grit Andersen, et al. · British Journal of Clinical Pharmacology · 14
PDF
First‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist for endothelial protection
2020 · Luc Bergougnan, Sara Armani, et al. · British Journal of Clinical Pharmacology · 14
PDF
Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice
2023 · Allyson Anding, Sofia Kinton, et al. · Journal of Pharmacology and Experimental Therapeutics · 13
PDF
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
2020 · Haiyan Li, Yudong Wei, et al. · American Journal of Cardiovascular Drugs · 11
PDF
Aza-indolizine with bridgehead nitrogen. Metalation, halogen-metal exchange and directed ortho-lithiation in the imidazo[1,2-a]pyrazine series
1998 · Olivier Vitse, Jacques Bompart, et al. · Tetrahedron · 11
A phase I trial assessing the safety, pharmacokinetics, cerebrospinal fluid penetrance, and food effect of BTK inhibitor tolebrutinib in healthy volunteers
2024 · Marie‐José Cabanis, Olivier Nicolas, et al. · Clinical and Translational Science · 10
PDF
Nitration in the imidazo[1,2‐a]pyrazine series. Experimental and computational results
1997 · Olivier Vitse, Pierre‐Antoine Bonnet, et al. · Journal of Heterocyclic Chemistry · 9
Metalation and halogen‐metal exchange in the imidazo[1,2‐a]quinoxaline series
2001 · Stéphanie Parra, Olivier Vitse, et al. · Journal of Heterocyclic Chemistry · 5
Final results of a phase Ib study of isatuximab (ISA) plus pomalidomide (Pom) and dexamethasone (dex) in relapsed/refractory multiple myeloma (RRMM).
2018 · Joseph Mikhael, Paul G. Richardson, et al. · Journal of Clinical Oncology · 4
Relaxant and phosphodiesterase inhibition activities of Imidazo[1,2-a]pyrazine derivatives
1996 · F Laurent, Karine Portet, et al. · Fundamental and Clinical Pharmacology · 4
Absorption, Metabolism, and Excretion of [14C]-Tolebrutinib After Oral Administration in Humans, Contribution of the Metabolites to Pharmacological Activity
2023 · Olivier Nicolas, Patricia Moliner, et al. · Clinical Drug Investigation · 3
PDF
[SCA 40 and derivatives: new bronchodilators in an imidazo(1,2-a)pyrazine series].
1998 · P A Bonnet, O Vitse, et al. · PubMed · 1
Pharmacodynamics, Pharmacokinetics And Safety Of Alirocumab In Healthy Chinese Subjects
2019 · H. Li, Y. Wei, et al. · Atherosclerosis
ChemInform Abstract: Metalation and Halogen—Metal Exchange in the Imidazo[1,2‐a]quinoxaline Series.
2001 · Stephanie Parra, Olivier Vitse, et al. · ChemInform
ChemInform Abstract: Aza‐Indolizine with Bridgehead Nitrogen. Metalation, Halogen‐Metal Exchange and Directed ortho‐Lithiation in the Imidazo[1,2‐a]pyrazine Series.
1998 · O. VITSE, J. BOMPART, et al. · ChemInform
ChemInform Abstract: Nitration in the Imidazo(1,2‐a)pyrazine Series. Experimental and Computational Results.
1997 · O. VITSE, P.‐A. BONNET, et al. · ChemInform
Etude pharmacochimique en série imidazo[1,2-a]pyrazine : Synthèse, réactivité (substitution électrophile, métallation) et activité bronchodilatatrice
1997 · Olivier Vitse
Works count: 19
Citation count: 176
H-index: 9
I10-index: 8
Year
Topic
Type